Table 3 Proportion of participants with improvements and degradations in HbA1c by ≥0.5%, ≥1.0%, ≥1.5% compared to baseline
Proportion of experimental participants (%) | Proportion of control participants (%) | Proportion difference (%) [95% CI] | p value | |
---|---|---|---|---|
HbA1c improvement (%) | ||||
≥0.5 | 52 | 31 | 21 [0.4 to 40] | 0.048 |
≥1.0 | 19 | 10 | 10 [−6 to 25] | 0.21 |
≥1.5 | 12 | 5 | 7 [−6 to 21] | 0.24 |
HbA1c degradation (%) | ||||
≥0.5 | 2 | 21 | −19 [−33 to −5] | 0.0074 |
≥1.0 | 2 | 7 | −5 [−17 to 6] | 0.31 |
≥1.5 | 0 | 2 | −2 [−12 to 6] | 0.32 |